DK2155179T3 - Axomadol til smertebehandling arthrose - Google Patents

Axomadol til smertebehandling arthrose

Info

Publication number
DK2155179T3
DK2155179T3 DK08758440.5T DK08758440T DK2155179T3 DK 2155179 T3 DK2155179 T3 DK 2155179T3 DK 08758440 T DK08758440 T DK 08758440T DK 2155179 T3 DK2155179 T3 DK 2155179T3
Authority
DK
Denmark
Prior art keywords
axomadol
arthrosis
pain management
pain
management
Prior art date
Application number
DK08758440.5T
Other languages
English (en)
Inventor
Klaus Schiene
Petra Bloms-Funke
John Bothmer
Claudia Lefeber
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK2155179T3 publication Critical patent/DK2155179T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK08758440.5T 2007-05-11 2008-05-09 Axomadol til smertebehandling arthrose DK2155179T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007022790A DE102007022790A1 (de) 2007-05-11 2007-05-11 Axomadol zur Schmerzbehandlung bei Arthrose
PCT/EP2008/003755 WO2008138558A1 (de) 2007-05-11 2008-05-09 Axomadol zur schmerzbehandlung bei arthrose

Publications (1)

Publication Number Publication Date
DK2155179T3 true DK2155179T3 (da) 2011-03-07

Family

ID=39672675

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08758440.5T DK2155179T3 (da) 2007-05-11 2008-05-09 Axomadol til smertebehandling arthrose

Country Status (22)

Country Link
US (2) US20080306161A1 (da)
EP (1) EP2155179B1 (da)
JP (1) JP2010526786A (da)
KR (1) KR20100017781A (da)
CN (1) CN101742993A (da)
AT (1) ATE489947T1 (da)
AU (1) AU2008250621A1 (da)
CA (1) CA2685379A1 (da)
CY (1) CY1111328T1 (da)
DE (2) DE102007022790A1 (da)
DK (1) DK2155179T3 (da)
ES (1) ES2357355T3 (da)
HK (1) HK1141436A1 (da)
HR (1) HRP20110127T1 (da)
IL (1) IL202001A0 (da)
MX (1) MX2009012096A (da)
PL (1) PL2155179T3 (da)
PT (1) PT2155179E (da)
RU (1) RU2009145804A (da)
SI (1) SI2155179T1 (da)
WO (1) WO2008138558A1 (da)
ZA (1) ZA200907646B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008298A2 (en) * 2009-07-16 2011-01-20 Nectid, Inc. Novel axomadol dosage forms
US20110053914A1 (en) 2009-08-28 2011-03-03 Gruenenthal Gmbh Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic
WO2011029614A1 (en) 2009-09-14 2011-03-17 Grünenthal GmbH Crystalline modifications of 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol
US20120022294A1 (en) * 2010-06-30 2012-01-26 Gruenenthal Gmbh Axomadol or a Metabolite Thereof for Use in the Treatment of Irritable Bowel Syndrome

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE10004926A1 (de) * 2000-02-04 2001-08-09 Gruenenthal Gmbh Verfahren zur enzymatischen Racematspaltung von Aminomethyl-Aryl-Cyclohexanol-Derivaten
DE10059413A1 (de) * 2000-11-30 2002-06-20 Gruenenthal Gmbh Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz
US20050176790A1 (en) * 2001-02-28 2005-08-11 Johannes Bartholomaus Pharmaceutical salts
DE10109763A1 (de) 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmazeutische Salze
DE10146275A1 (de) * 2001-09-18 2003-04-24 Gruenenthal Gmbh Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz
SI1685829T1 (sl) * 2002-11-22 2008-08-31 Gruenenthal Gmbh Uporaba (1RS,3RS,6RS)-6-dimetilaminometil-1- (3-metoksi-fenil)-cikloheksan-1, 3-diola za zdravljenje vnetne bolečine
DE10333835A1 (de) * 2003-07-24 2005-03-10 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol enthaltendes Arzneimittel mit verzögerter Wirkstofffreisetzung
CA2572491A1 (en) * 2004-07-01 2006-01-12 Gruenenthal Gmbh Oral dosage form safeguarded against abuse
DE102005009217A1 (de) * 2005-02-25 2006-08-31 Grünenthal GmbH Phosphatsalze der 6-Dimethylaminomethyl-1-(3-methoxyphenyl)-1,3-dihydroxy-cyclohexanverbindungen
CA2598579A1 (en) * 2005-02-25 2006-08-31 Gruenenthal Gmbh Crystalline forms of (1rs,3rs,6rs)-6-dimethvlaminomethvl-1-(3-methoxv- phenyl)cyclohexane-1 ,3-diol hydrochloride

Also Published As

Publication number Publication date
EP2155179B1 (de) 2010-12-01
AU2008250621A1 (en) 2008-11-20
KR20100017781A (ko) 2010-02-16
RU2009145804A (ru) 2011-06-20
ZA200907646B (en) 2010-07-28
IL202001A0 (en) 2010-06-16
ATE489947T1 (de) 2010-12-15
SI2155179T1 (sl) 2011-03-31
DE502008001951D1 (de) 2011-01-13
PT2155179E (pt) 2011-03-07
HRP20110127T1 (hr) 2011-03-31
DE102007022790A1 (de) 2008-11-20
CY1111328T1 (el) 2015-08-05
EP2155179A1 (de) 2010-02-24
WO2008138558A1 (de) 2008-11-20
US20100331424A1 (en) 2010-12-30
CA2685379A1 (en) 2008-11-20
CN101742993A (zh) 2010-06-16
PL2155179T3 (pl) 2011-05-31
HK1141436A1 (en) 2010-11-12
ES2357355T3 (es) 2011-04-25
US20080306161A1 (en) 2008-12-11
MX2009012096A (es) 2009-11-23
JP2010526786A (ja) 2010-08-05

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201171367A1 (ru) Винилиндазолильные соединения
GB2464245A (en) Managing risk associated with various transactions
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
CL2008002042A1 (es) Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos.
EA201001372A1 (ru) Формы рифаксимина и их применение
RS53893B1 (en) USE OF BIOTIN FOR MULTIPLE SCLEROSIS TREATMENT
MY160041A (en) Compositions and methods for treating parasitic infections
EA200970737A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
CL2012003385A1 (es) Tratamiento para la incontinencia.
CR20110658A (es) Antagonistas de la trayectoria hedgehog de ftalazina desustituida
EA201170832A1 (ru) Пуриновые соединения
EA201170252A1 (ru) Амидофеноксиндазолы в качестве ингибиторов c-мет
RS53466B (en) USE OF AMISULPRID FOR THE TREATMENT OF POSTOPERATIVE Nausea and Vomiting
EA201071248A1 (ru) Дизамещенные фталазиновые антагонисты пути hedgehog
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
BRPI0820440A2 (pt) Inibidores aldh-2 no tratamento de desordens psiquiátricas
MX2009011346A (es) Tapentadol para tratamiento de dolor con artritis.
BRPI0810384A2 (pt) Terapia enzimática anticâncer
BRPI0822129A2 (pt) Inibidores de aldh-2c no tratamento de vício.
UA103468C2 (ru) Соединения циклоалкилокси- и гетероциклоалкилоксипиридина как модуляторы гистаминового рецептора н3
DK2155179T3 (da) Axomadol til smertebehandling arthrose